This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Eberhard Karls Universitaet Tuebingen, Mayo Foundation for Medical Education and Research, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 12 
2 out of 1,810 
1 out of 15 
Years Active: 2011-2013
Title: The Innovative Contributions of Jennifer M Kachergus
Introduction
Jennifer M Kachergus is a prominent inventor based in Atlantic Beach, FL (US). She has made significant strides in the field of neurodegenerative disorders through her innovative research and discoveries. With a total of 2 patents, her work focuses on the KASPP (LRRK2) gene, which has implications for the detection and treatment of various neurodegenerative diseases.
Latest Patents
Kachergus's latest patents revolve around the KASPP (LRRK2) gene, which is crucial for understanding and addressing neurodegenerative disorders. This invention details the production, biochemical characterization, and application of the KASPP gene for detecting and treating conditions such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis. The research highlights several polymorphisms and mutations in the KASPP/LRRK2 gene that are associated with Parkinson's disease, showcasing the potential for targeted therapies.
Career Highlights
Throughout her career, Kachergus has worked with esteemed institutions such as Eberhard Karls Universität Tübingen and the Mayo Foundation for Medical Education and Research. Her contributions to the field have been recognized for their potential to transform the understanding and treatment of neurodegenerative disorders.
Collaborations
Kachergus has collaborated with notable colleagues, including Thomas Meitinger and Tim Matthias Strom. These partnerships have further enriched her research and expanded the impact of her findings in the scientific community.
Conclusion
Jennifer M Kachergus stands out as an influential inventor in the realm of neurodegenerative research. Her work on the KASPP (LRRK2) gene not only advances scientific knowledge but also holds promise for developing effective treatments for debilitating diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile